Suppr超能文献

医疗器械开发的责任与后果。

The liabilities and consequences of medical device development.

作者信息

Price J M

出版信息

J Biomed Mater Res. 1987 Apr;21(A1 Suppl):35-58.

PMID:3571302
Abstract

A large increase in medical products liability litigation during the past 40 years has resulted in a flood of litigation against drug and device manufacturers. The medical technology and chemical industries are prime targets for products liability litigation. Physicians and other health care providers are willing to accept a reasonable degree of risk associated with the use of a medical product when compared to the benefit to be achieved by that product but lay juries are less likely to tolerate the concept of an acceptable failure rate. Plaintiffs' lawyers believe that the medical products industry should be held to a standard of absolute liability and that anyone injured by a medical product is entitled to recover without regard for the circumstances. Large compensatory and punitive damage awards, the high cost of insurance, large defense costs, and low profit margins have forced some companies to remove their products from the market. The medical or biomaterials manufacturer can significantly reduce its exposure for products liability by adopting a successful product safety program. Manufacturers have significant control over the quality, safety, and reliability of their products through appropriate design, testing, manufacture, labeling, and sale of quality products.

摘要

在过去40年里,医疗产品责任诉讼大幅增加,导致针对药品和器械制造商的诉讼泛滥成灾。医疗技术和化工行业是产品责任诉讼的主要目标。与使用医疗产品所带来的益处相比,医生和其他医疗保健提供者愿意接受与使用该产品相关的合理程度的风险,但普通陪审团不太可能容忍可接受故障率的概念。原告律师认为,医疗产品行业应遵循绝对责任标准,任何因医疗产品而受伤的人都有权获得赔偿,而无需考虑具体情况。巨额的补偿性和惩罚性损害赔偿裁决、高昂的保险成本、庞大的辩护费用以及微薄的利润率,迫使一些公司将其产品撤出市场。医疗或生物材料制造商可以通过实施成功的产品安全计划,显著降低其面临的产品责任风险。制造商通过对产品进行适当的设计、测试、制造、标签标注以及销售优质产品,对其产品的质量、安全性和可靠性拥有重大控制权。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验